NuVasive Inc (NUVA.OQ)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|53||2015||Chairman of the Board, Chief Executive Officer|
|50||2017||Chief Financial Officer, Executive Vice President|
|52||2016||Executive Vice President, General Counsel, Corporate Secretary|
|52||2015||Executive Vice President - External Affairs and Corporate Marketing|
|53||2015||Executive Vice President, Global Human Resources, Integrations, Real Estate and Internal Communications|
- BRIEF-NuVasive Inc reports Q3 GAAP earnings per share $0.64
- BRIEF-NuVasive announces $100 million share repurchase program
- BRIEF-NuVasive receives expanded FDA 510(k) clearance For TLX Interbody System used in TLIF procedures
- BRIEF-NuVasive receives expanded FDA 510(k) clearance for innovative magnetic limb lengthening technology
- NuVasive sues former executive who moved to rival Alphatec